QT Imaging receives approval to uplist to NASDAQ

QT Imaging Holdings Inc. (OTCQB: QTIH) announced it received approval to uplist its common stock from the OTCQB Venture Market to the Nasdaq Capital Market. The medical device company's shares are expected to begin trading on Nasdaq under the ticker symbol "QTI" on Wednesday, January 28, 2026.

The company develops radiation-free breast imaging technology using low frequency sound waves. QT Imaging met all Nasdaq Capital Market listing requirements, including financial, corporate governance, and regulatory criteria.

"We returned to Nasdaq after less than one year of being delisted," said Chief Executive Officer Dr. Raluca Dinu in a statement. She described the approval as representing work to rebuild the company's business model and balance sheet.

QT Imaging was previously delisted from Nasdaq and had been trading on the OTCQB market. The company focuses on research, development, and commercialization of body imaging systems for medical applications.

The uplisting follows the company's efforts to meet exchange requirements after its prior delisting. QT Imaging stated the Nasdaq listing aligns with its strategy of expanding its global presence and advancing technological development.

The company holds the trademark for Breast Acoustic CT technology through an affiliate. QT Imaging is based in Novato, California, and develops imaging systems intended for detection, diagnosis, and treatment applications in healthcare settings.

You May Also Be Interested In